[HTML][HTML] Circulating tumour cells in gastrointestinal cancers: food for thought?

S Asawa, M Nüesch, A Gvozdenovic… - British Journal of Cancer, 2023 - nature.com
Gastrointestinal (GI) cancers account for 35% of cancer-related deaths, predominantly due
to their ability to spread and generate drug-tolerant metastases. Arising from different …

Post‐diagnosis dietary factors, supplement use and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and …

DSM Chan, M Cariolou, G Markozannes… - … journal of cancer, 2024 - Wiley Online Library
The role of diet in colorectal cancer prognosis is not well understood and specific lifestyle
recommendations are lacking. We searched for randomised controlled trials (RCTs) and …

[HTML][HTML] Comparative study of organoids from patient-derived normal and tumor colon and rectal tissue

A Costales-Carrera, A Fernández-Barral… - Cancers, 2020 - mdpi.com
Colon and rectal tumors, often referred to as colorectal cancer, show different gene
expression patterns in studies that analyze whole tissue biopsies containing a mix of tumor …

[HTML][HTML] Function and mechanisms of microRNA‑20a in colorectal cancer

Z Xiao, S Chen, S Feng, Y Li, J Zou… - Experimental and …, 2020 - spandidos-publications.com
Colorectal cancer (CRC) is the third most common malignancy and the second leading
cause of cancer‑associated mortality worldwide. CRC currently has no specific biomarkers …

[HTML][HTML] Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (CtDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer …

S Chakrabarti, AK Kasi, AR Parikh, A Mahipal - Cancers, 2022 - mdpi.com
Simple Summary After the surgical removal of colorectal cancer (CRC), residual cancer cells
undetectable by standard blood tests and imaging studies are responsible for cancer …

[HTML][HTML] LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer

R Tang, J Chen, M Tang, Z Liao, L Zhou… - … Journal of Biological …, 2019 - ncbi.nlm.nih.gov
It is universally acknowledged that long non-coding RNAs (lncRNAs) involved in
tumorigenesis in human cancers. However, the function and mechanism of many lncRNAs …

[HTML][HTML] The prognostic significance of serum lactate dehydrogenase-to-albumin ratio in colorectal cancer

U Aday, A Böyük, H Akkoç - Annals of Surgical Treatment and …, 2020 - ncbi.nlm.nih.gov
Purpose The purpose of our study was initially to explore the prognostic role of LDH-to-
albumin ratio in patients with colorectal carcinoma (CRC) undergoing curative resection …

[HTML][HTML] The gut microbiota metabolite urolithin B prevents colorectal carcinogenesis by remodeling microbiota and PD-L1/HLA-B

L Wang, J Chen, Q Chen, H Song… - Oxidative Medicine …, 2023 - preview.hindawi.com
Colorectal cancer has risen to the third occurring cancer in the world. Fluorouracil (5-Fu),
oxaliplatin, and cisplatin are the most effective chemotherapeutic agents for clinical …

Follow-up of colorectal cancer and patterns of recurrence

PD Haria, AD Baheti, D Palsetia, SK Ankathi… - Clinical Radiology, 2021 - Elsevier
Colorectal cancer is one of the commonest cancers detected as also amongst the most
common causes of cancer death. Survival has improved due to better disease …

[HTML][HTML] Risk factors of recurrence in TNM stage I colorectal cancer

JH Paik, CG Ryu, DY Hwang - Annals of Surgical Treatment and …, 2023 - ncbi.nlm.nih.gov
Purpose TNM stage I colorectal cancer (CRC) can recur, although the recurrence rate is low.
Few studies have evaluated the risk factors for TNM stage I CRC recurrence. This study …